This episode of the Posh Corps Podcast investigates Peace Corps’ use of the anti-malarial drug Mefloquine. This story is the third segment in The Reform Series, a four-part series about Peace Corps reform efforts.
Mefloquine, also known by the brand name Lariam, is an anti-malarial drug that has been prescribed to Peace Corps Volunteers since 1989. Mefloquine is effective at preventing malaria, but some believe that the adverse side effects of the drug may be just as dangerous as malaria itself.
Sara Thompson served as a Peace Corps Volunteer in Burkina Faso from 2010 to 2012. She experienced serious adverse side effects from Mefloquine use during service, and the side effects did not end when she stopped taking the drug.
Posh Corps Podcast, Mefloquine, Episode 15, 15 May 2016.
Joe Palazzo, Former peace corps volunteer sues over malaria drug, Wall Street Journal, 27 March 2015.
Alan Zarembo, FDA warns about anti-malaria drug, Los Angeles Times, 2 August 2013.
Maggie Fox, FDA strengthens warnings on malaria drug, NBC News, 29 July 2013.